- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07797374
Postoperative Nausea, Vomiting and Pain After Bariatric Surgery - a National Registry Study (BAROSPOR)
Pain and Nausea in the Post-Anaesthesia Care Unit After Bariatric Surgery: A Registry Study Linking the Swedish Perioperative Register (SPOR) and the Scandinavian Obesity Surgery Registry (SOReg)
Around 4,000-5,000 bariatric (weight-loss) operations are performed in Sweden every year. Nausea, vomiting and pain are common immediately after these operations, cause considerable suffering and increase the intensity and length of hospital care. Bariatric surgery is one of the procedures with the highest risk of postoperative nausea and vomiting (PONV): about one third of patients experience PONV already in the recovery unit, and registry data indicate that around 40% report severe pain at the same stage.
This study links two national quality registries - the Swedish Perioperative Register (SPOR) and the Scandinavian Obesity Surgery Registry (SOReg) - to describe how often adult patients experience nausea, vomiting and pain in the post-anaesthesia care unit after primary bariatric surgery, and to identify patient, anaesthetic and surgical factors associated with these outcomes. The study tests whether total intravenous anaesthesia, the addition of a regional nerve block, and preoperative health-related quality of life are associated with PONV and pain, and whether early PONV or pain is associated with complications, unplanned hospital care or reoperation up to one year after surgery. The results are intended to show how well current evidence on preventing PONV and pain is applied in everyday practice and where care can be improved.
Study Overview
Status
Detailed Description
BACKGROUND Bariatric surgery is common in Sweden with 4,000-5,000 procedures per year. Data on each operation are recorded in the Swedish Perioperative Register (SPOR), covering more than 90% of all surgical procedures in Sweden with automatic data transfer from hospital IT systems, and in the Scandinavian Obesity Surgery Registry (SOReg), with a coverage of approximately 98% of bariatric surgery. Postoperative nausea and vomiting (PONV) and pain are frequent after bariatric surgery. Evidence-based guidelines exist, but 25-40% of surgical patients still experience PONV, and up to 50% may experience severe postoperative pain. Risk factors are validated at a general level but not specifically for bariatric surgery.
OBJECTIVES
- To describe the risk of early PONV and pain in the post-anaesthesia care unit (PACU) after primary bariatric surgery.
- To identify factors associated with early PONV and pain.
- To test the hypotheses that total intravenous anaesthesia (compared with inhalational anaesthesia) and the addition of a regional block are associated with lower risk of PONV or pain in the PACU; that poorer preoperative health-related quality of life (RAND-36) is associated with higher risk of PONV, pain and severe pain; and that PONV or pain in the PACU is associated with higher risk of postoperative complications up to one year after surgery. Separate hypothesis tests are performed for PONV and pain.
DESIGN Exploratory observational cohort study based on registry data. Patients aged 18 years or older with a primary bariatric procedure registered in SOReg during 2018-2027 are identified. Records are linked to SPOR by Uppsala Clinical Research Center (UCR) using personal identity number and date of surgery (+/- 3 days). If several SPOR records fall within the interval, each is included as a separate row with an index variable linking to the SOReg operation. Each individual is assigned a unique serial number and the dataset delivered to the research group contains pseudonymised data only. Data extractions are made at most once per year from 2025; the first analyses cover 2018-2023.
VARIABLES From SOReg: preoperative data (patient characteristics, comorbidity, laboratory values, preoperative work-up, RAND-36), operative data (procedure type, technique, intraoperative complications) and postoperative follow-up up to one year (complications, hospital care, reoperation). From SPOR: patient characteristics, process data, operative data (diagnosis, procedure, anaesthesia type, times, deviations), postoperative data (pain, nausea/vomiting, deviations, level of care) and date of death.
STATISTICAL ANALYSIS Descriptive statistics with univariable and multivariable analysis of associations. Candidate variables include sex, age, comorbidity, preoperative pain, anaesthesia type, procedure type, surgical technique and length of stay. The expected sample is approximately 70% of all bariatric operations in Sweden, about 3,000 patients per year; the main reason for exclusion is expected to be missing PACU registration of pain and/or nausea at some hospitals. As the study includes more than half of the target population, no formal power calculation is performed.
DATA PROTECTION Only pseudonymised data are handled. Data are stored at Umeå University with access restricted to the study researchers, in accordance with current legislation.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Jakob Walldén, MD, PhD
- Phone Number: +46 60 14 52 55
- Email: jakob.wallden@umu.se
Study Locations
-
-
-
Sundsvall, Sweden, 851 86
- Recruiting
- Sundsvall Hospital, Department of Anaesthesia and Intensive Care
-
Umeå, Sweden, 901 87
- Recruiting
- Umeå University, Department of Diagnostics and Intervention
-
Sub-Investigator:
- Antonio Moraitis, MD
-
Contact:
- Jakob Walldén, MD, PhD
- Phone Number: +46 60 14 52 55
- Email: jakob.wallden@umu.se
-
Principal Investigator:
- Jakob Walldén, MD, PhD
-
Sub-Investigator:
- Magnus Hultin, MD, PhD
-
Sub-Investigator:
- Yucel Cengiz, MD, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 18 years or older
- Primary bariatric surgery registered in SOReg during 2018-2027
Exclusion Criteria:
- Revision bariatric surgery
- If more than one bariatric operation is registered for the same patient, only the primary operation is included
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Adults undergoing primary bariatric surgery in Sweden 2018-2027
Patients aged 18 years or older with a primary bariatric procedure registered in the Scandinavian Obesity Surgery Registry (SOReg) 2018-2027 and a matching operation record in the Swedish Perioperative Register (SPOR).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of postoperative nausea and/or vomiting in the post-anaesthesia care unit
Time Frame: During the stay in the post-anaesthesia care unit (approximately 0-4 hours after surgery)
|
Number of operations with registered nausea and/or vomiting in the PACU divided by the total number of operations.
Source: SPOR variable "Illamående postoperativt" (postoperative nausea).
|
During the stay in the post-anaesthesia care unit (approximately 0-4 hours after surgery)
|
|
Pain intensity in the post-anaesthesia care unit, numerical rating scale (NRS) 0-10
Time Frame: During the stay in the post-anaesthesia care unit (approximately 0-4 hours after surgery)
|
Median NRS score (0 = no pain, 10 = worst imaginable pain).
Source: SPOR variables "Smärta inom 1 tim efter ankomst UVA" (pain within 1 hour of PACU arrival) and "Smärta postoperativt, högsta" (highest postoperative pain).
|
During the stay in the post-anaesthesia care unit (approximately 0-4 hours after surgery)
|
|
Incidence of severe pain in the post-anaesthesia care unit
Time Frame: During the stay in the post-anaesthesia care unit (approximately 0-4 hours after surgery)
|
Number of operations with NRS >= 7 divided by the total number of operations.
|
During the stay in the post-anaesthesia care unit (approximately 0-4 hours after surgery)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of patients with postoperative complications, unplanned hospital care or reoperation - 6 weeks
Time Frame: Up to 6 weeks after surgery
|
Complications (including Clavien-Dindo grade), unplanned hospital care and reoperation as registered in SOReg at the 6-week follow-up.
|
Up to 6 weeks after surgery
|
|
Proportion of patients with postoperative complications, unplanned hospital care or reoperation - 1 year
Time Frame: Up to 1 year after surgery
|
Complications (including Clavien-Dindo grade), unplanned hospital care and reoperation as registered in SOReg at the 1-year follow-up.
|
Up to 1 year after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jakob Walldén, MD, PhD, Umeå University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pain
- Neurologic Manifestations
- Postoperative Complications
- Pathologic Processes
- Nutrition Disorders
- Overnutrition
- Body Weight
- Signs and Symptoms, Digestive
- Overweight
- Obesity
- Vomiting
- Nausea
- Pathological Conditions, Signs and Symptoms
- Nutritional and Metabolic Diseases
- Signs and Symptoms
- Pain, Postoperative
- Postoperative Nausea and Vomiting
- Obesity, Morbid
Other Study ID Numbers
- BAROSPOR-2025-01
- 2025 (U.S. NIH Grant/Contract: Faculty of Social Sciences Scientific Grant at the University of Gdańsk)
- 2025-00877-01 (Other Identifier: Swedish Ethical Review Authority (Etikprovningsmyndigheten))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.